Literature DB >> 4150321

Relationship between plasma antipyrine half-lives and hepatic microsomal drug metabolism in dogs.

E S Vesell, C J Lee, G T Passananti, C A Shively.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4150321     DOI： 10.1159/000136453

Source DB:  PubMed          Journal:  Pharmacology        ISSN： 0031-7012            Impact factor:   2.547


× No keyword cloud information.
  10 in total

1.  Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation.

Authors:  D J Greenblatt; M D Allen; D S MacLaughlin; D H Huffman; J S Harmatz; R I Shader
Journal:  J Pharmacokinet Biopharm       Date:  1979-04

2.  Drug metabolism in epileptics: in vivo and in vitro correlations.

Authors:  E A Sotaniemi; R O Pelkonen; J Ahokas; H I Pirttiaho; J Ahlqvist
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics in veterinary medicine.

Authors:  J D Baggot
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

4.  Absence of changes in drug disposition and catecholamine sensitivity in the hyperthyroid dog.

Authors:  T Ishizaki; K Tawara
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

5.  The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man.

Authors:  C J Roberts; L Jackson; M Halliwell; R A Branch
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

6.  Cholestasis and hepatic drug metabolism. Comparison of metabolic clearance rate of antipyrine in patients with intrahepatic or extrahepatic cholestasis.

Authors:  J P Miguet; D Vuitton; J P Deschamps; H Allemand; C Joanne; P Bechtel; P Carayon
Journal:  Dig Dis Sci       Date:  1981-08       Impact factor: 3.199

7.  Antipyrine elimination in saliva after low-dose combined or progestogen-only oral contraceptive steroids.

Authors:  D M Chambers; G C Jefferson; M Chambers; N B Loudon
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

8.  Altered elimination of antipyrine in patients with acute viral hepatitis.

Authors:  D A Burnett; A J Barak; D J Tuma; M F Sorrell
Journal:  Gut       Date:  1976-05       Impact factor: 23.059

9.  m-Trifluoromethyl-alpha-ethylbenzhydrol: a new enzyme inducer.

Authors:  B Gachályi; A Káldor; S Szeberényi
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

Review 10.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.